Teva Pharmaceutical Industries Ltd. — Director's Dealing 2019

May 20, 2019

_________ false

��� ������ ��������� ��"�	2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954	10817
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	20/05/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-048295	Time of broadcast: 14:46 14:46:41

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

	Delay the publication of a report	_________	_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on����� �� ����� ������� ����� ����

FORM_4__JEANM_2019518_41223_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE	Date of revision of form structure: 30/04/2019
Address: P.O.B 3190 , Petach Tikva 49131   , Tel: 03-9267267 , 03-9267652 Fax: 03-9267519
E-mail address: tomer.amitai@teva.co.il
Previous names of reporting entity:
Name of the Signatory: Beck Codner Iris Position of Signatory in the reporting corporation: Vice President, Global Corporate Communication Name of Employer Company:
Address: Basel 5 , Petach Tikva 49131 Telephone: 03-9267208 Facsimile: 03-9267851 E-mail: iris.beckcodner@teva.co.il 1